AVACTA GROUP PLC — AGM Information 2014

Jan 24, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4991Y

Avacta Group PLC

24 January 2014

Avacta Group plc

("Avacta" or the "Group")

Result of AGM

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, announces that at its Annual General Meeting held today, all resolutions put to shareholders were duly passed.

Following the Annual General Meeting, Gwyn Humphreys stood down as Chairman of the Company and Tony Robards stood down from the Board with immediate effect. Trevor Nicholls, who joined the board as a Non-Executive Director in September 2013, will take over as Chairman and Mr Humphreys remains on the board as a Non-executive Director.  Trevor has considerable senior-level commercial experience including as Chief Commercial Officer and Executive Vice President of Affymetrix. His experience of commercialising products in the life sciences sector will be of great benefit to Avacta as it grows over the coming few years.  The Board wishes to thank Gwyn and Tony for their contributions over the past few years in their respective roles.

Ends -

Enquiries:

Avacta Group plc	www.avacta.com
Alastair Smith, Chief Executive Officer	Tel:  +44 (0) 844 414 0452
Tim Sykes, Chief Financial Officer
Numis Securities Limited		Tel:  +44 (0) 20 7260 1000
Michael Meade / Freddie Barnfield (NOMAD)
James Black  (Corporate Broking)
Walbrook PR Limited	Tel: 020 7933 8780 or avacta@walbrookpr.com
Anna Dunphy	Mob: 07876 741 001
Lianne Cawthorne	Mob: 07584 391 303

About Avacta Group plc - www.avacta.com

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:

Avacta Analytical www.avactaanalytical.com	High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development.
Avacta Animal Health www.avactaanimalhealth.com	Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod.
Avacta Life Sciences www.avactalifesciences.com	Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

Avacta joined AIM in August 2006 and is based in Wetherby, England.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGEALFLASSLEFF